The issue with Samsung from a credibility standpoi
Post# of 145754
![](/assets/46931549/no_avatar_available_thumb.jpg)
But BTD, BLA acceptance, major licensing deal, investment from a top tier pharma fund, -- even a top-tier pharma player on the BOD -- those will undoubtedly move the credibility needle.
(Even one mainstream publication mentioning LERO would be a big step up from what we have today).
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)